203 related articles for article (PubMed ID: 8275922)
1. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
Besançon G; Cousin R; Guitton B; Lavergne F
Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
Daléry J; Aubin V
Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
[TBL] [Abstract][Full Text] [Related]
3. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
Schöne W; Ludwig M
Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression].
Dalery J; Rochat C; Peyron E; Bernard G
Encephale; 1992; 18(3):257-62. PubMed ID: 1299597
[TBL] [Abstract][Full Text] [Related]
5. [Validation of HARD (Hamilton depression rating scale) a diagram of the evaluation of depression by MADRS (Montgomery-Asberg depression rating scale) Multicentric study of mianserin].
Ferreri M; Cousin FR; Rufin JC; Alby JM
Encephale; 1986; 12(6):343-50. PubMed ID: 3545786
[TBL] [Abstract][Full Text] [Related]
6. Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders.
Manna V; Martucci N; Agnoli A
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():81-8. PubMed ID: 2644342
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.
Geretsegger C; Böhmer F; Ludwig M
Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578
[TBL] [Abstract][Full Text] [Related]
8. [Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine].
Dalery J; Bouhassira M; Kress JP; Lancrenon S; Tafani A; Hantouche EG
Encephale; 1995; 21(3):217-25. PubMed ID: 7649072
[TBL] [Abstract][Full Text] [Related]
9. A controlled study of mianserin in moderately to severely depressed outpatients.
Carman JS; Ahdieh H; Wyatt-Knowles E; Warga E; Panagides J
Psychopharmacol Bull; 1991; 27(2):135-9. PubMed ID: 1924659
[TBL] [Abstract][Full Text] [Related]
10. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
11. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
[TBL] [Abstract][Full Text] [Related]
13. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of once-daily flupenthixol and mianserin in depressed hospital out-patients.
Majid I
Pharmatherapeutica; 1986; 4(7):405-10. PubMed ID: 3515368
[TBL] [Abstract][Full Text] [Related]
15. A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients.
Muijen M; Roy D; Silverstone T; Mehmet A; Christie M
Acta Psychiatr Scand; 1988 Sep; 78(3):384-90. PubMed ID: 3057817
[TBL] [Abstract][Full Text] [Related]
16. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
Rabkin JG; Rabkin R; Wagner G
J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
[TBL] [Abstract][Full Text] [Related]
19. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
20. [Depressive symptomatology and sleep apnea syndrome].
Pochat MD; Ferber C; Lemoine P
Encephale; 1993; 19(6):601-7. PubMed ID: 12404778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
